Abstract
Intrathecal drug delivery with implantable, programmable, and continuous drug delivery systems has provided an effective means to treat refractory pain of malignant and nonmalignant origin. Understanding of the delivery devices, as well as the skills to effectively use the technology, is paramount for successful patient care.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Recommended Reading
Deer T. Atlas if implantable therapies for pain management. New York: Springer Science Business Media; 2016.
Deer T, Hyaek S, Pope JE, Lamer TJ, Hamza M, Grider JS, Rosen S, Narouse S, Perruchoud C, Thompson S, Russo M, Grisby E, Doleys DM, Jacobs MS, Saulino M, Christo P, Kim P, Huntoon M, Krames E, Mekhail N. Polyanalgesic consensus conference guidelines for IT drug delivery: guidance for improving safety and mitigating risks. Neuromodulation. 2017;20(2):155–76.
Deer T, Hyaek S, Pope JE, Lamer TJ, Hamza M, Grider JS, Rosen S, Narouse S, Perruchoud C, Thompson S, Russo M, Grisby E, Doleys DM, Jacobs MS, Saulino M, Christo P, Kim P, Huntoon M, Krames E, Mekhail N. Polyanalgesic consensus conference (PACC) recommendations on intrathecal drug infusion systems best practices and guidelines. Neuromodulation. 2017;20(2):96–132.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Kim, C.H. (2019). Intrathecal Device Considerations. In: Deer, T., Pope, J., Lamer, T., Provenzano, D. (eds) Deer's Treatment of Pain. Springer, Cham. https://doi.org/10.1007/978-3-030-12281-2_81
Download citation
DOI: https://doi.org/10.1007/978-3-030-12281-2_81
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-12280-5
Online ISBN: 978-3-030-12281-2
eBook Packages: MedicineMedicine (R0)